RecruitingNot ApplicableNCT07637500

Refocus VisAbility™ Micro Insert System Pre-market Clinical Trial

A Prospective, Multicenter Clinical Trial To Evaluate The Safety And The Improvement In Near Visual Acuity In Presbyopic Patients Treated With The VisAbility™ Micro Insert System Through 12 Months

Sponsor

Refocus Group, Inc.

Enrollment

33 participants

Start Date

Jun 2, 2026

Study Type

INTERVENTIONAL

Conditions

Presbyopia

Summary

The primary study objective is to evaluate the safety and effectiveness of the VisAbility™ Micro Insert System for improvement in binocular distance corrected near visual acuity in presbyopic patients.

Eligibility

Min Age: 45 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called VisAbility™ Micro Insert System for people with presbyopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 45 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.